Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises

doi:10.3389/fphar.2022.1065124

. 2022 Nov 16:13:1065124.

doi: 10.3389/fphar.2022.1065124. eCollection 2022.

Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises

Prakasini Satapathy¹, Radha Kanta Ratho¹, Sunil Sethi²

Affiliations

¹ Department of Virology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

PMID: 36467096
PMCID: PMC9709319
DOI: 10.3389/fphar.2022.1065124

Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises

Prakasini Satapathy et al. Front Pharmacol. 2022.

. 2022 Nov 16:13:1065124.

doi: 10.3389/fphar.2022.1065124. eCollection 2022.

Authors

Prakasini Satapathy¹, Radha Kanta Ratho¹, Sunil Sethi²

Affiliations

¹ Department of Virology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

PMID: 36467096
PMCID: PMC9709319
DOI: 10.3389/fphar.2022.1065124

No abstract available

Keywords: COVID; Mycobacterium tuberculosis (M Tuberculosis); biomarkers (MESH D015415); coinfections; treatment regimens.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Cited by

Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns.
Chiok KR, Dhar N, Banerjee A. Chiok KR, et al. iScience. 2023 May 19;26(5):106629. doi: 10.1016/j.isci.2023.106629. Epub 2023 Apr 8. iScience. 2023. PMID: 37091987 Free PMC article. Review.
Coinfections in Tuberculosis in Low- and Middle-Income Countries: Epidemiology, Clinical Implications, Diagnostic Challenges, and Management Strategies-A Narrative Review.
Cioboata R, Balteanu MA, Osman A, Vlasceanu SG, Zlatian OM, Mitroi DM, Catana OM, Socaci A, Tieranu EN. Cioboata R, et al. J Clin Med. 2025 Mar 21;14(7):2154. doi: 10.3390/jcm14072154. J Clin Med. 2025. PMID: 40217604 Free PMC article. Review.

References

1. Abdalla A. E., Lambert N., Duan X., Xie J. (2016). Interleukin-10 family and tuberculosis: An old story renewed. Int. J. Biol. Sci. 12 (6), 710–717. 10.7150/ijbs.13881 - DOI - PMC - PubMed
1. Aborode A. T., Corriero A. C., Fajemisin E. A., Hasan M. M., Kazmi S. K., Olajiga O. (2022). Dengue and Coronavirus disease (COVID‐19) syndemic: Double threat to an overburdened healthcare system in Africa. Int. J. Health Plann. Manage. 37 (3), 1851–1854. 10.1002/hpm.3334 - DOI - PMC - PubMed
1. Amelio P., Portevin D., Hella J., Reither K., Kamwela L., Lweno O., et al. (2019). “HIV infection functionally impairs Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses,”J. Virol. Editor Silvestri G., 93. 10.1128/JVI.01728-18 5 - DOI - PMC - PubMed
1. Boulle A., Davies M-A., Hussey H., Ismail M., Morden E., Vundle Z., et al. (2021). Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the western cape Province, South Africa. Clin. Infect. Dis. 73 (7), e2005–e2015. 10.1093/cid/ciaa1198 - DOI - PMC - PubMed
1. Cascella M., Rajnik M., Aleem A., Dulebohn S. C., Di Napoli R. (2022). Features, evaluation, and treatment of coronavirus (COVID-19). Available at: http://www.ncbi.nlm.nih.gov/pubmed/32150360 . - PubMed

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

[1] Abdalla A. E., Lambert N., Duan X., Xie J. (2016). Interleukin-10 family and tuberculosis: An old story renewed. Int. J. Biol. Sci. 12 (6), 710–717. 10.7150/ijbs.13881 - DOI - PMC - PubMed

[2] Abdalla A. E., Lambert N., Duan X., Xie J. (2016). Interleukin-10 family and tuberculosis: An old story renewed. Int. J. Biol. Sci. 12 (6), 710–717. 10.7150/ijbs.13881 - DOI - PMC - PubMed

[3] Aborode A. T., Corriero A. C., Fajemisin E. A., Hasan M. M., Kazmi S. K., Olajiga O. (2022). Dengue and Coronavirus disease (COVID‐19) syndemic: Double threat to an overburdened healthcare system in Africa. Int. J. Health Plann. Manage. 37 (3), 1851–1854. 10.1002/hpm.3334 - DOI - PMC - PubMed

[4] Aborode A. T., Corriero A. C., Fajemisin E. A., Hasan M. M., Kazmi S. K., Olajiga O. (2022). Dengue and Coronavirus disease (COVID‐19) syndemic: Double threat to an overburdened healthcare system in Africa. Int. J. Health Plann. Manage. 37 (3), 1851–1854. 10.1002/hpm.3334 - DOI - PMC - PubMed

[5] Amelio P., Portevin D., Hella J., Reither K., Kamwela L., Lweno O., et al. (2019). “HIV infection functionally impairs Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses,”J. Virol. Editor Silvestri G., 93. 10.1128/JVI.01728-18 5 - DOI - PMC - PubMed

[6] Amelio P., Portevin D., Hella J., Reither K., Kamwela L., Lweno O., et al. (2019). “HIV infection functionally impairs Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses,”J. Virol. Editor Silvestri G., 93. 10.1128/JVI.01728-18 5 - DOI - PMC - PubMed

[7] Boulle A., Davies M-A., Hussey H., Ismail M., Morden E., Vundle Z., et al. (2021). Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the western cape Province, South Africa. Clin. Infect. Dis. 73 (7), e2005–e2015. 10.1093/cid/ciaa1198 - DOI - PMC - PubMed

[8] Boulle A., Davies M-A., Hussey H., Ismail M., Morden E., Vundle Z., et al. (2021). Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the western cape Province, South Africa. Clin. Infect. Dis. 73 (7), e2005–e2015. 10.1093/cid/ciaa1198 - DOI - PMC - PubMed

[9] Cascella M., Rajnik M., Aleem A., Dulebohn S. C., Di Napoli R. (2022). Features, evaluation, and treatment of coronavirus (COVID-19). Available at: http://www.ncbi.nlm.nih.gov/pubmed/32150360 . - PubMed

[10] Cascella M., Rajnik M., Aleem A., Dulebohn S. C., Di Napoli R. (2022). Features, evaluation, and treatment of coronavirus (COVID-19). Available at: http://www.ncbi.nlm.nih.gov/pubmed/32150360 . - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises

Affiliations

Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Miscellaneous